オプションチェーンは、Nature's Miracle Holdingの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Nature's Miracle Holdingの市場センチメントを評価します。.

Nature's Miracle Holding (NASDAQ:NMHI) 株価情報, オプションチェーン

Nature's Miracle Holding

Nature's Miracle Holding Inc is a growing agriculture technology company providing Controlled Environment Agriculture (CEA) hardware products to growers in the CEA industry setting in North America. It provides hardware to design, build, and operate various indoor growing settings, including greenhouse and indoor growing spaces. Its products include Horticultural Lighting, Irrigation System, Power Distribution Systems, Climate Control Systems, Disinfection Systems, and Materials And Equipment.

Nature's Miracle Holding Inc. - Common Stock

Nature's Miracle Holding Inc

Boundless Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOLD#NASDAQ">BOLD</a>) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.82) by 9.76 percent.

Earnings

Earnings Beats

News

BOLD

Boundless Bio Q3 2024 GAAP EPS $(0.74) Beats $(0.82) Estimate

Sports betting and iGaming company DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) reported third-quarter financial results<a href="https://www.benzinga.com/earnings"> after market close Thursday.</a>
Here are the key highlights.
What Happened: DraftKings reported third-quarter revenue of $1.095 billion, up 39% year-over-year. The revenue total missed a Street consensus estimate of $1.112 billion according to data <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110724&amp;t=be2bearmibe3na1">from Benzinga Pro.</a>
The company said revenue growth came from strong customer engagement, the acquisition of new customers, the launch in new territories, and the impact of the acquisition of Jackpocket, which closed in May.
The company reported a loss of 17 cents per share, which beat a Street consensus estimate of a loss of 42 cents per share.
Monthly unique payers (MUP) were 3.6 million in the third quarter, up 55% year-over-year. Excluding the impact of the Jackpocket acquisition, monthly unique payers would have been up 27% year-over-year.
The average revenue per MUP was $103 in the third quarter, down 10% year over year. The lower revenue per payer was due to the Jackpocket acquisition. Excluding the Jackpocket acquisition, the average revenue per MUP was 8% higher year over year.
"DraftKings delivered strong performance in the third quarter with the return of NFL and college football," DraftKings CEO Jason Robins said.
DraftKings was live for mobile sports betting in 25 states and Washington D.C., representing 49% of the U.S. population in the third quarter. The company is also live with iGaming in five states and live for both sportsbook and iGaming in Ontario, Canada.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41792879/draftkings-q3-earnings-highlights-nfl-in-focus-will-missouri-legalization-factor-in">DraftKings Q3 Earnings Preview: NFL In Focus, Will Missouri Legalization Factor Into Guidance?</a>
What's Next: The company lowered its fiscal year 2024 revenue guidance from a range of $5.05 billion to $5.25 billion to a new range of $4.85 billion to $4.95 billion due to customer-friendly sport outcomes in the fourth quarter, which comes with the NFL season having several weeks of favorable outcomes for bettors.
Analysts expect the company to report revenue of $5.14 billion for the full fiscal year, according to data from Benzinga Pro.
The company also revised its 2024 adjusted EBITDA guidance from a range of $340 million to $420 million to a new range of $240 million to $280 million.
DraftKings introduced fiscal year 2025 revenue guidance for the first time, with a range of $6.2 billion to $6.6 billion expected. The company also said it expects 2025 adjusted EBITDA to be in a range of $900 million to $1.0 billion, reaffirming guidance from August.
"With major sports converging on the calendar, we are well-positioned to build on this momentum as we further enhance our top-ranked sportsbook app with additional live betting features and exciting new NBA markets," Robins said. "Our focus remains on driving sustainable revenue growth and profitability in 2025 and beyond."
The company's 2024 and 2025 guidance includes all existing mobile sports betting and iGaming markets and Jackpocket, but does not include any pending state launches.
Missouri legalized sports betting on Election Day 2024 and DraftKings expects to launch its sportsbook in the state pending approval. The company also expects to launch its sportsbook in Puerto Rico, which is pending approval.
DKNG Price Action: DraftKings stock is down 5% to $37.00 in after-hours trading Thursday, versus a 52-week trading range of $28.69 to $49.57.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41725070/draftkings-offers-10k-in-prizes-for-2024-election-predictions-harris-trump-swing-state-performan">DraftKings Offers $10K In Prizes For 2024 Election Predictions: Harris, Trump Swing State Performance Among Key Questions</a></li>
</ul>
Photo: Shutterstock

Sports Betting

Movers

Trading Ideas

DKNG

DraftKings Q3 Highlights: Revenue Miss, 2024 Guidance Trim, First 2025 Outlook, CEO Reaffirms Focus On 'Sustainable Revenue Growth'

WIIM

QRHC

Quest Resources shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Eventbrite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.13) by 69.23 percent. This is a 60 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $77.80 million which beat the analyst consensus estimate of $75.83 million by 2.60 percent. This is a 4.59 percent decrease over sales of $81.54 million the same period last year.

Eventbrite Q3 EPS $(0.04) Beats $(0.13) Estimate, Sales $77.80M Beat $75.83M Estimate

Arlo Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>) is looking for Q4 Adj EPS of $0.07-0.13 vs $0.11 analyst estimate. sees sales of $116.000 million-126.000 million vs $138.94 million estimate.

Guidance

ARLO

Arlo Technologies Sees Q4 Adj EPS $0.07-0.13 vs $0.11 Est; Sees Sales $116.000M-126.000M vs $138.94M Est

Lucid Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) reported third-quarter financial results after the market close on Thursday. Here&#8217;s a look at the key metrics from the <a href="https://www.benzinga.com/pressreleases/24/11/n41823730/lucid-announces-third-quarter-2024-financial-results">electric vehicle company&#8217;s quarter</a>.
Q3 Earnings: Lucid reported third-quarter revenue of $200.04 million, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $197.97 million, according to <a href="http://pro.benzinga.com" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The EV company reported an adjusted quarterly loss of 28 cents per share, beating analyst estimates for a loss of 30 cents per share.
Lucid said it produced 1,805 vehicles in the third quarter and delivered 2,781.&nbsp;The company ended the quarter with approximately $5.16 billion in total liquidity.
&#8220;Our momentum continues with our third consecutive quarter of record deliveries,&#8221; said&nbsp;Peter Rawlinson, CEO and CTO of Lucid.
 &#8220;Additionally, today we are delighted to open the order book for the much-anticipated Lucid Gravity SUV, a landmark product, which remains on track for start of production this year. Furthermore, our recent capital raise of approximately&nbsp;$1.75&nbsp;billion serves to further secure the future of the company by extending its financial runway well into 2026.&#8221;
Related Link: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
Outlook: Lucid said it remains on track to produce approximately 9,000 vehicles in 2024.
The company announced Thursday morning that its&nbsp;Gravity Grand Touring&nbsp;SUV became available to order. Lucid expects production to start at the end of the year.
&#8220;We continue to see improvements to gross margin performance as our cost reduction efforts are gaining momentum,&#8221; said&nbsp;Gagan Dhingra, interim CFO and principal accounting officer at Lucid.&nbsp;
Management will hold a conference call to further discuss the company&#8217;s quarterly results at 5:30 p.m. ET.
LCID Price Action: <a href="https://www.benzinga.com/quote/LCID" target="_blank" rel="noreferrer noopener">Lucid shares</a> were up 8.09% in after-hours, trading at $ 2.39 at the time of publication, according to <a href="http://pro.benzinga.com" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Courtesy of Lucid.

After-Hours Center

LCID

Lucid Q3 Earnings: Revenue Beat, EPS Beat, On Track To Produce 9K Vehicles In 2024

Management

COLL

Collegium Names Vikram Karnani As CEO, Effective Nov. 12; Former Horizon Therapeutics Executive To Lead Growth And Expansion

FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $140.209 million which missed the analyst consensus estimate of $143.138 million by 2.05 percent. This is a 1.51 percent decrease over sales of $142.364 million the same period last year.

Earnings Misses

FIGS

FIGS Q3 2024 Adj. EPS $(0.01), Inline, Sales $140.209M Miss $143.138M Estimate

Potbelly (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBPB#NASDAQ">PBPB</a>) .

PBPB

Potbelly FY2024 Guidance: Same Store Sales -1.2% to -0.5%, Adj. EBITDA $29.5M-$30.5M.

Gross margin in the range of 70% to 71%, up from previous guidance range of 68% to 70%.
&nbsp;
&nbsp;

RXST

RxSight Now Sees FY24 Revenue At The Top Of Previously Provided Guidance Range Of $139M - $140M, Est $139.642M

Dividends

EOG Resources Raises Quarterly Dividend From $0.91 To $0.975

Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.33) by 33.33 percent. This is a 21.43 percent increase over losses of $(0.28) per share from the same period last year.

RZLT

Rezolute Q1 EPS $(0.22) Beats $(0.33) Estimate

JFBR

Jeffs' Brands shares are trading higher after the company announced it entered into a non-binding letter of intent for the sale of a subsidiary valued at $13.5 million.

Design Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGN#NASDAQ">DSGN</a>) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.31) by 25.81 percent.

DSGN

Design Therapeutics Q3 2024 GAAP EPS $(0.23) Beats $(0.31) Estimate

Cantaloupe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTLP#NASDAQ">CTLP</a>) reported quarterly earnings of $0.04 per share which met the analyst consensus estimate. This is a 100 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $70.84 million which missed the analyst consensus estimate of $71.74 million by 1.26 percent. This is a 13.01 percent increase over sales of $62.68 million the same period last year.

CTLP

Cantaloupe Q1 EPS $0.04, Inline, Sales $70.84M Miss $71.74M Estimate

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fidentiv.com&amp;esheet=54148677&amp;newsitemid=20241107448252&amp;lan=en-US&amp;anchor=Identiv%2C+Inc&amp;index=1&amp;md5=7038f21113fe10c77c0bb35b935bf53b">Identiv, Inc</a><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fidentiv.com&amp;esheet=54148677&amp;newsitemid=20241107448252&amp;lan=en-US&amp;anchor=.&amp;index=2&amp;md5=99b6eaee914a3599ca5133f57d2023b0">.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>), a global leader in RFID-enabled Internet of Things (IoT) solutions, today announced that its Board of Directors has authorized a stock repurchase program for up to $10 million of its common stock. The Company also announced its Board of Directors intends to propose changes to the Company's corporate governance policies in advance of the 2025 annual meeting of stockholders.

Buybacks

INVE

Identiv Announces $10M Stock Repurchase Program

Potbelly 4Q 24 Guidance: Same Store Sales -2.5% to -0.5%, Adj. EBITDA $7M-$8M.

PACB

Pacific Biosciences Says On The Path To Return To Growth In 2025 And Beyond

Adeia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADEA#NASDAQ">ADEA</a>) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.39 by 30.77 percent. The company reported quarterly sales of $86.101 million which missed the analyst consensus estimate of $111.128 million by 22.52 percent. This is a 15.09 percent decrease over sales of $101.397 million the same period last year.

ADEA

Adeia Q3 2024 Adj. EPS $0.27 Misses $0.39 Estimate, Sales $86.101M Miss $111.128M Estimate

Block Sees FY24 Adj. EBITDA $2.90B

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nature&rsquo;s Miracle&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) stock is on the rise Tuesday alongside heavy pre-market trading of the agriculture technology company&rsquo;s shares.



This has more than 11 million shares of NMHI stock changing hands as of this writing. That&rsquo;s quite the surge compared to the company&rsquo;s daily average trading volume of about 82,000 shares. Its float is also <a href="https://finance.yahoo.com/quote/NMHI/key-statistics/">only 8.07 million units</a>.



There is no news from Nature&rsquo;s Miracle that explains why the stock is up today. However, it could be due to its connection to the cannabis market. It sells lighting and fixtures used by cannabis growers. That sector has been of interest lately with some seeing newly-announced presidential candidate Kamala Harris as <a href="https://www.usatoday.com/story/news/nation/2024/07/22/kamala-harris-marijuana-stance-policy/74495543007/">positive on marijuana legalization</a>.



It&rsquo;s also worth mentioning that NMHI is a penny stock. That comes from its low daily average trading volume, prior closing price of just 35 cents and its market capitalization of only $9.26 million.



<h2>What That Means for NMHI Stock</h2>



All of this shows that Nature&rsquo;s Miracle&rsquo;s shares are subject to volatility. This can happen as speculative traders pile into a company&rsquo;s stock. That might be happening this morning alongside the current Vice President securing the Democratic presidential candidate position.



NMHI stock is up 94.2% as of Tuesday morning.



Investors will want to stick around for more of the most recent stock market stories!



We have all of the hottest stock market news investors need to know about on Tuesday! Among that is what has shares of Warrantee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock up, the biggest pre-market stock movers this morning and more. All of that info is ready at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-warrantee-wrnt-stock-up-129-today/">Why Is Warrantee (WRNT) Stock Up 129% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Tuesday</a></li>



<li><a href="https://investorplace.com/2024/07/amc-stock-pops-on-news-company-will-restructure-debt/">AMC Stock Pops on News Company Will Restructure Debt</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">Why Is Nature's Miracle (NMHI) Stock Up 94% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Nature's Miracle (NMHI) Stock Up 94% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
TransCode Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is taking a beating on Tuesday after the biopharmaceutical company announced the pricing for a public offering of its shares.



TransCode Therapeutics is <a href="https://www.nasdaq.com/press-release/transcode-therapeutics-inc-announces-pricing-public-offering-2024-07-22">selling 10 million shares</a> of its common stock for 30 cents each. This has it expecting to raise gross proceeds of $30 million from the public offering of RNAZ stock.



TransCode Therapeutics says it will use the money from this offering mostly for product development activities. That includes more clinical trials of TTX-MC138. This is its lead product candidate for the treatment of metastatic tumors.



<h2>What This Means for RNAZ Stock</h2>



A public offering increases the total number of outstanding shares on the market. That&rsquo;s a blow to current investors in RNAZ as it reduces their stakes in the company. This is one reason why TransCode Therapeutics&rsquo; stock is falling today.



On top of that, the public offering price is a significant discount over its prior closing price of 79 cents. It makes sense that the price of RNAZ stock would drop with it offering news shares for just 30 cents each.



RNAZ stock is down 62.1% as of Tuesday morning. That comes with about 1.4 million shares traded, as compared to a daily average of around 1.3 million shares.



Investors will want to stick around for more of the most recent stock market stories!



We have all of the hottest stock market news investors need to know about on Tuesday! A few examples include what&rsquo;s happening with shares of Nature&rsquo;s Miracle&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) and Warrantee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock, as well as the biggest pre-market stock movers this morning. All of this info is ready to go at the links below!



<h2>More Tuesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">Why Is Nature&rsquo;s Miracle (NMHI) Stock Up 94% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-warrantee-wrnt-stock-up-129-today/">Why Is Warrantee (WRNT) Stock Up 129% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Tuesday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-transcode-therapeutics-rnaz-stock-down-62-today/">Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mira Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) stock is down on Tuesday as the clinical-stage pharmaceutical company&rsquo;s shares come off of a major rally on Monday.



Shares of MIRA stock closed out Monday&rsquo;s normal trading hours up 627.4%. That came alongside heavy trading with <a href="https://finance.yahoo.com/quote/MIRA/">more than 153 million shares traded</a>. For comparison, its daily average trading volume is about 3.2 million shares.



Mira Pharmaceuticals stock experienced this rally after releasing data from a <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">pre-clinical study of Ketamir-2</a>. This is the company&rsquo;s novel oral ketamine analog designed to treat neurological and neuropsychiatric disorders.



The big news here is that the results were positive. This has the company excited about the prospect of furthering the development of Ketamir-2 and submitting an investigational new drug (IND) application for it.



<h2>MIRA Stock Movement on Tuesday</h2>



Considering the massive rally MIRA shares underwent yesterday, it makes sense they would give up some of those gains in the days to follow. This has the stock dropping 27.4% as of Tuesday morning.



Today&rsquo;s dip comes with more than 5.5 million shares changing hands this morning. That&rsquo;s already above its daily average trading volume but is well below yesterday&rsquo;s heavy trading.



Investors who are seeking out even more of the most recent stock market stories today will want to keep reading!



We have all of the hottest stock market news that traders need to know about on Tuesday! That includes everything happening with shares of TransCode Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock, Nature&rsquo;s Miracle&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>)&nbsp;stock and Warrantee&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock today. All of this info is ready to go at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-transcode-therapeutics-rnaz-stock-down-62-today/">Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/trade-of-the-day-buy-sentinelone-s-stock-amid-cybersecurity-carnage/">Trade of the Day: Buy SentinelOne (S) Stock Amid Cybersecurity Carnage</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">Why Is Nature&rsquo;s Miracle (NMHI) Stock Up 94% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-down-27-today/">Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!



Moving stocks this morning are earnings reports, a clinical trial update, acquisition news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock is rocketing close to 121% <a href="https://www.nasdaq.com/press-release/windtree-therapeutics-provides-update-istaroxime-clinical-development-and-upcoming">on a clinical trial update</a>.</li>



<li>BurgerFi International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) shares are soaring more than 93% <a href="https://www.nasdaq.com/press-release/burgerfi-reaches-legal-settlement-agreement-lion-point-capital-lp-2024-07-25">on a settlement agreement</a>.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is surging over 65% on a <a href="https://www.nasdaq.com/press-release/carbon-revolution-supplies-carbon-fiber-wheels-chevrolet-corvette-zr1-2024-07-25">supply deal with Chevrolet</a>.</li>



<li>Everi (NYSE:<a href="https://investorplace.com/stock-quotes/evri-stock-quote/">EVRI</a>) shares are gaining more than 35% <a href="https://www.nasdaq.com/press-release/igts-gaming-and-digital-business-and-everi-be-acquired-simultaneously-apollo-funds">on an acquisition deal</a>.</li>



<li>Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) stock is increasing over 26% with its <a href="https://www.businesswire.com/news/home/20240725452896/en/Coursera-Reports-Second-Quarter-2024-Financial-Results">latest earnings report</a>.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are rising more than 24% alongside heavy pre-market trading.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) stock is heading over 21% higher with strong early morning trading.</li>



<li>Nova Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVA#NASDAQ">NVA</a>) shares are climbing more than 20% <a href="https://www.tipranks.com/news/company-announcements/nova-minerals-issues-millions-of-new-warrants">after issuing new warrants</a>.</li>



<li>International Game Technology (NYSE:<a href="https://investorplace.com/stock-quotes/igt-stock-quote/">IGT</a>) stock is jumping over 20% alongside the <a href="https://www.prnewswire.com/news-releases/igts-gaming-and-digital-business-and-everi-to-be-acquired-simultaneously-by-apollo-funds-in-all-cash-transaction-302207429.html">Everi acquisition news</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are up more than 17% on Friday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is crashing more than 40% without any clear news this morning.</li>



<li>DexCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/dxcm-stock-quote/">DXCM</a>) shares are plummeting over 34% on <a href="https://www.nasdaq.com/press-release/dexcom-reports-second-quarter-2024-financial-results-updates-guidance-and-announces">poor Q2 results and a cut outlook</a>.</li>



<li>Advent Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/adn-stock-quote/">ADN</a>) stock is diving more than 33% despite a lack of news this morning.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are tumbling over 30% after <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">rallying earlier this week</a>.</li>



<li>Zynex (NASDAQ:<a href="https://investorplace.com/stock-quotes/zyxi-stock-quote/">ZYXI</a>) stock is taking a nearly 23% beating with its <a href="https://www.nasdaq.com/press-release/zynex-reports-second-quarter-2024-financial-results-2024-07-25">Q2 earnings report</a>.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) shares are sliding more than 22% <a href="https://www.nasdaq.com/press-release/ocean-power-technologies-inc-announces-fourth-quarter-and-full-year-fiscal-2024">alongside its latest earnings report</a>.</li>



<li>Renovaro (NASDAQ:<a href="https://investorplace.com/stock-quotes/renb-stock-quote/">RENB</a>) stock is dropping over 18% without any obvious news to report.</li>



<li>Avinger (NASDAQ:<a href="https://investorplace.com/stock-quotes/avgr-stock-quote/">AVGR</a>) shares are falling almost 15% this morning.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is decreasing 14% after rallying yesterday.</li>



<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares close out our pre-market stock movers down more than 13.5% after jumping yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Nature's Miracle Holding stock plummets on pricing of $1.2M public offering

Nature's Miracle Holding (NMHI) has issued an announcement. On July 17, 2024, Nature's Miracle Holding Inc. sold a $180,000 convertible note and a ...

Nature's Miracle Holding Concludes Convertible Note Agreement

An update from Nature's Miracle Holding (NMHI) is now available. Nature's Miracle Holding Inc. has reached an agreement with Darin Carpenter for hi...

Nature's Miracle Holding Announces COO Transition and Stock Vesting

Nature's Miracle Holding GAAP EPS of -$0.07, revenue of $3.4M

Nature's Miracle enters debt reduction agreement with Uninet Global

Nature's Miracle (NMHI) announced it has entered into a Cooperation Agreement with Robostreet to order a total of 150 LS450 electric trucks from Ro...

Nature's Miracle enters Cooperation Agreement with Robostreet

AVGR

BLMZ

COUR

CREV

DXCM

EVRI

MIRA

NMHI

OPTT

PAPL

RENB

RNAZ

SLNA

WINT

WRNT

XCUR

ZPTA

ZYXI

Commodities

Press Releases

Nature's Miracle Announces Participation in the Emerging Growth Virtual Conference

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now

Nature's Miracle Announces Participation in the H.C. Wainwright Annual Global Investment Conference

Nature's Miracle Holding Inc. Confirms $2.1 Million Debt Reduction Agreement with Uninet Global

Nature's Miracle Holding Inc. Launches Wholly Owned Subsidiary, NM Rebate Inc. to Complement Core LED Lighting Segment

Contracts

Nature's Miracle Holding Inc. Announces Agreement with Robostreet to Launch Mobile E Farm in California

Nature's Miracle Announces Participation in NobleCon20 - Noble Capital Markets' 20th Annual Emerging Growth Equity Conference

Nature's Miracle Holding Inc. to Exhibit its LED Light, Dehumidifier and Other Products at the 13th Annual MJBizCon

Nature's Miracle Holding Inc. Launches EV Business in the United States and South America

Comments

Nature's Miracle Holding

Nature's Miracle Holding (NMHI) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル